| 000 | 01589 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515001518.0 | ||
| 264 | 0 | _c20070914 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a1543-0790 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlshehadat, Saaib | |
| 245 | 0 | 0 |
_aProphylactic cranial irradiation in limited-stage small-cell lung cancer: a retrospective analysis. _h[electronic resource] |
| 260 |
_bClinical advances in hematology & oncology : H&O _cJun 2004 |
||
| 300 |
_a397-400 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain Neoplasms _xprevention & control |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aCranial Irradiation |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHospitals, Community _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNorth Dakota _xepidemiology |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTreatment Refusal |
| 700 | 1 | _aSahmoun, Abe E | |
| 773 | 0 |
_tClinical advances in hematology & oncology : H&O _gvol. 2 _gno. 6 _gp. 397-400 |
|
| 999 |
_c15796437 _d15796437 |
||